Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA.
Goldberg SB, Narayan A, Kole AJ, Decker RH, Teysir J, Carriero NJ, Lee A, Nemati R, Nath SK, Mane SM, Deng Y, Sukumar N, Zelterman D, Boffa DJ, Politi K, Gettinger SN, Wilson LD, Herbst RS, Patel AA. Goldberg SB, et al. Among authors: gettinger sn. Clin Cancer Res. 2018 Apr 15;24(8):1872-1880. doi: 10.1158/1078-0432.CCR-17-1341. Epub 2018 Jan 12. Clin Cancer Res. 2018. PMID: 29330207 Free PMC article.
HER-1, 2, and 3.
Gettinger S. Gettinger S. J Thorac Oncol. 2011 Nov;6(11 Suppl 4):S1793-6. doi: 10.1097/01.JTO.0000407561.68910.a1. J Thorac Oncol. 2011. PMID: 22005533 Free article. No abstract available.
Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay.
Anagnostou VK, Dimou AT, Botsis T, Killiam EJ, Gustavson MD, Homer RJ, Boffa D, Zolota V, Dougenis D, Tanoue L, Gettinger SN, Detterbeck FC, Syrigos KN, Bepler G, Rimm DL. Anagnostou VK, et al. Among authors: gettinger sn. Cancer. 2012 Mar 15;118(6):1607-18. doi: 10.1002/cncr.26450. Epub 2011 Aug 25. Cancer. 2012. PMID: 22009766 Free article.
Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial.
Socinski MA, Stinchcombe TE, Moore DT, Gettinger SN, Decker RH, Petty WJ, Blackstock AW, Schwartz G, Lankford S, Khandani A, Morris DE. Socinski MA, et al. Among authors: gettinger sn. J Clin Oncol. 2012 Nov 10;30(32):3953-9. doi: 10.1200/JCO.2012.41.9820. Epub 2012 Oct 8. J Clin Oncol. 2012. PMID: 23045594 Clinical Trial.
Immune therapies for lung cancer.
Gettinger S. Gettinger S. J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S394-6. doi: 10.1097/JTO.0b013e31826df203. J Thorac Oncol. 2012. PMID: 23160331 Free article. Review. No abstract available.
136 results